Bonnet, M; Roper, C; Felix, M; Coulibaly, L; Kankolongo, GM; Guthmann, JP; (2007) Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore. Malaria journal, 6. ISSN 1475-2875 DOI: https://doi.org/10.1186/1475-2875-6-54

Dorsey, G; Dokomajilar, C; Kiggundu, M; Staedke, SG; Kamya, MR; Rosenthal, PJ; (2004) Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. The American journal of tropical medicine and hygiene, 71 (6). pp. 758-63. ISSN 0002-9637 https://researchonline.lshtm.ac.uk/id/eprint/10209

Staedke, SG; Sendagire, H; Lamola, S; Kamya, MR; Dorsey, G; Rosenthal, PJ; (2004) Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Tropical medicine & international health, 9 (5). pp. 624-9. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2004.01239.x Full text not available from this repository.

Dorsey, G; Vlahos, J; Kamya, MR; Staedke, SG; Rosenthal, PJ; (2003) Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. The Journal of infectious diseases, 188 (8). pp. 1231-8. ISSN 0022-1899 DOI: https://doi.org/10.1086/378523 Full text not available from this repository.

Omar, SA; Adagu, IS; Warhurst, DC; (2001) Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Transactions of the Royal Society of Tropical Medicine and Hygiene, 95 (3). pp. 315-9. ISSN 0035-9203 https://researchonline.lshtm.ac.uk/id/eprint/16300 Full text not available from this repository.